The anti-apoptotic effects of HMG-CoA reductase inhibitors on vascular endothelial cells is mediated by ASK1 suppression

被引：0

作者：

Kataoka, Keiichiro ^{[1
]}

Kim-Mitsuyama, Shokei ^{[1
]}

机构：

[1] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto, Japan

来源：

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2008年 / 44卷 / 02期

关键词：

HMG-CoA reductase inhibitor; ASK1; apoptosis;

D O I：

10.1016/j.yjmcc.2007.07.028

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：443 / 443

页数：1

共 50 条

[21] The Effects of Combined Treatment with an HMG-CoA Reductase Inhibitor and PPARγ Agonist on the Activation of Rat Pancreatic Stellate Cells [J].

Lee, Beom Jae ;

Lee, Hong Sik ;

Kim, Chang Duck ;

Jung, Sung Woo ;

Seo, Yeon Seok ;

Kim, Yong Sik ;

Jeen, Yoon Tae ;

Chun, Hoon Jai ;

Um, Soon Ho ;

Lee, Sang Woo ;

Choi, Jai Hyun ;

Ryu, Ho Sang .

GUT AND LIVER, 2012, 6 (02) :262-269

[22] Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells [J].

Shi, Libin ;

Ding, Wenghui ;

Li, Dayuan ;

Wang, Zhijian ;

Jiang, Hongfeng ;

Zhang, Junhua ;

Tang, Chaoshu .

ATHEROSCLEROSIS, 2006, 188 (02) :260-264

[23] Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation [J].

Won, M. ;

Park, K. A. ;

Byun, H. S. ;

Sohn, K-C ;

Kim, Y-R ;

Jeon, J. ;

Hong, J. H. ;

Park, J. ;

Seok, J. H. ;

Kim, J. M. ;

Yoon, W-H ;

Jang, I-S ;

Shen, H. M. ;

Liu, Z. G. ;

Hur, G. M. .

CELL DEATH AND DIFFERENTIATION, 2010, 17 (12) :1830-1841

[24] Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits [J].

Mitani, H ;

Bandoh, T ;

Ishikawa, J ;

Kimura, M ;

Totsuka, T ;

Hayashi, S .

BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (06) :1269-1275

[25] Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation [J].

M Won ;

K A Park ;

H S Byun ;

K-C Sohn ;

Y-R Kim ;

J Jeon ;

J H Hong ;

J Park ;

J H Seok ;

J M Kim ;

W-H Yoon ;

I-S Jang ;

H M Shen ;

Z G Liu ;

G M Hur .

Cell Death & Differentiation, 2010, 17 :1830-1841

[26] Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells [J].

Denoyelle, C ;

Albanese, P ;

Uzan, G ;

Hong, L ;

Vannier, JP ;

Soria, J ;

Soria, C .

CELLULAR SIGNALLING, 2003, 15 (03) :327-338

[27] Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin [J].

Wilcox, LJ ;

Barrett, PHR ;

Huff, MW .

JOURNAL OF LIPID RESEARCH, 1999, 40 (06) :1078-1089

[28] HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway [J].

Qi, X-F ;

Zheng, L. ;

Lee, K-J ;

Kim, D-H ;

Kim, C-S ;

Cai, D-Q ;

Wu, Z. ;

Qin, J-W ;

Yu, Y-H ;

Kim, S-K .

CELL DEATH & DISEASE, 2013, 4 :e518-e518

[29] HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway [J].

X-F Qi ;

L Zheng ;

K-J Lee ;

D-H Kim ;

C-S Kim ;

D-Q Cai ;

Z Wu ;

J-W Qin ;

Y-H Yu ;

S-K Kim .

Cell Death & Disease, 2013, 4 :e518-e518

[30] Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia [J].

Nakamura, N ;

Hamazaki, T ;

Ohta, M ;

Okuda, K ;

Urakaze, M ;

Sawazaki, S ;

Yamazaki, K ;

Satoh, A ;

Temaru, R ;

Ishikura, Y ;

Takata, M ;

Kishida, M ;

Kobayashi, M .

INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1999, 29 (01) :22-25

← 1 2 3 4 5 →